DiaSorin – Medical Alley Association

DiaSorin

In The Know: Healthcare News for January 11, 2021

Tactile Medical Announces Sheri Dodd to Board of Directors UnitedHealth’s Optum to Buy Data Analytics Firm Change Healthcare in $13 Billion Deal Functional Neuromodulation Announces Breakthrough Device Designation from the U.S. FDA for Deep Brain Stimulation for Alzheimer’s Disease Bright Health Outperforms Expectations During Open Enrollment and Accelerates Its Membership Growth in 2021; Announces Agreement […]

In The Know: Healthcare News for November 23, 2020

B2 Mask Named to TIME’s List of 100 Best Inventions of 2020 BARDA Expands Partnership with DiaSorin Inc to Develop an Enhanced IgG Assay for Determining COVID-19 Patient Exposure and Immune Status Joe Biden’s Plan for COVID-19 and How the Industry is Reacting 3M Announces James Momon as Vice President, Equity & Community and Chief […]

IMPACT: Medical Alley and the COVID-19 Pandemic

Published October 15, 2020 Life, as we have known it, has changed. We celebrate the healthcare and public safety professionals, and the essential workers who continue to go to work every day to help others. We celebrate the acts of kindness and empathy; the countless recoveries and families reunited.  We continue to be in this […]

In The Know: Healthcare News for Sept. 14, 2020

Medtronic TTVR system wins breakthrough device designation Minnetronix Medical Gets FDA Clearance on Innovative Neurosurgical Access Platform FDA clears DiaSorin test that differentiates between COVID, flu Boston Scientific launches Vercise Genus DBS system in Europe Abilitech named Minne Inno’s ‘Women-led Startup of the Year’ Regulatory and Quality Solutions LLC (R&Q) Acquires Maetrics to Form the […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER